Diagnosis and Treatment of Osteoporosis. Department of Endocrinology and Metabolism Ajou University School of Medicine.

Similar documents
Osteoporosis. When we talk about osteoporosis, we have to be familiar with the constituents of bone and what it is formed of.

Osteoporosis. Overview

nogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

Bone Densitometry Pathway

Osteoporosis challenges

John J. Wolf, DO Family Medicine

Practical Management Of Osteoporosis

Current and Emerging Strategies for Osteoporosis

Osteoporosis/Fracture Prevention

Additional Research is Needed to Determine the Effects of Soy Protein on Calcium Binding and Absorption NDFS 435 3/26/2015. Dr.

COURSE OUTLINE - Module I

Clinical Practice. Presented by: Internist, Endocrinologist

Update on Osteoporosis 2016

Download slides:

SpongeBone Menopants*

Management of postmenopausal osteoporosis

Study of secondary causes of male osteoporosis

Breast Cancer and Bone Loss. One in seven women will develop breast cancer during a lifetime

OSTEOPOROSIS: PREVENTION AND MANAGEMENT

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS

Questions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss. A Publication of The Bone and Cancer Foundation

Ca, Mg metabolism, bone diseases. Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary

Osteoporosis: An Overview. Carolyn J. Crandall, MD, MS

Kristen M. Nebel, DO PENN/ LGHP Geriatrics. Temple Family Medicine Review

Osteoporosis. Open Access. John A. Kanis. Diseases, University of Sheffield, UK

[If no, skip to question 10.] Y N. 2. Does the member have a diagnosis of Paget s disease of bone? Y N. [If no, skip to question 4.

3. Has bone specific alkaline phosphatase level increased OR does the member have symptoms related to active Paget s?

Objectives: What is Osteoporosis 10/8/2015. Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING

Osteoporosis - New Guidelines. Michelle Glass B.Sc. (Pharm) June 15, 2011

Clinician s Guide to Prevention and Treatment of Osteoporosis

Musculoskeletal Clinical Correlates: Osseous Conditions in Dental Patients

Updates in Osteoporosis

Prevention and Treatment of OSTEOPOROSIS 骨質疏鬆的預防與治療

Bone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008

Osteoporosis Update. Greg Summers Consultant Rheumatologist

Updates in Osteoporosis. I have no conflicts of interest. What Would You Do? Mrs. C. What s New in Osteoporosis. Page 1

New Developments in Osteoporosis: Screening, Prevention and Treatment

Chau Nguyen, D.O. Rheumatologist Clinical Assistant Professor of Internal Medicine at Western University of Health Sciences

Disclosure and Conflicts of Interest Steven T Harris MD Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis

Page 1

Osteoporosis Treatment Overview. Colton Larson RFUMS October 26, 2018

Pathway from Fracture or Risk Factor to Treatment

Overview. Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases. People Centred Positive Compassion Excellence

Lab Guide Endocrine Section Lab Guide

Monitoring Osteoporosis Therapy

NEW DEVELOPMENTS IN OSTEOPOROSIS: SCREENING, PREVENTION AND TREATMENT

Questions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss. A Publication of The Bone and Cancer Foundation

Osteoporosis. Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective. Old Definition of Osteoporosis

in Primary Care (Part 2) Jonathan R. Anolik, MD, FACP, FACE Lewis Katz School of Medicine at Temple University

Agents that Affect Bone & Mineral Homeostasis

denosumab (Prolia ) Policy # Original Effective Date: 07/21/2011 Current Effective Date: 04/19/2017

Based on review of available data, the Company may consider the use of denosumab (Prolia) for the

HOW I DO IT. Introduction. BARKIN J. How I Do It: Managing bone health in patients with prostate cancer. Can J Urol 2014;21(4):

Osteoporosis/Fracture Prevention Clinician Guide SEPTEMBER 2017

Bone Metastases. Sukanda Denjanta, M.Sc., BCOP Pharmacy Department, Chiangrai Prachanukroh Hospital

Using the FRAX Tool. Osteoporosis Definition

Osteoporosis Agents Drug Class Prior Authorization Protocol

Drug Intervals (Holidays) with Oral Bisphosphonates

1

AACE/ACE Osteoporosis Treatment Decision Tool

BREAST CANCER AND BONE HEALTH

Advanced medicine conference. Monday 20 Tuesday 21 June 2016

What is Osteoporosis?

A Case of Cushing Syndrome Diagnosed by Recurrent Pathologic Fractures in a Young Woman

Effects of Anti RANK ligand Denosumab on Beta Thalassemia induced osteoporosis

Osteoporosis - Pathophysiology and diagnosis. Bente L Langdahl Department of Endocrinology Aarhus University Hospital Aarhus, Denmark

Case Report Combined Effect of a Locking Plate and Teriparatide for Incomplete Atypical Femoral Fracture: Two Case Reports of Curved Femurs

06-Mar-17. Premature menopause. Menopause. Premature menopause. Menstrual cycle oestradiol. Premature menopause. Prevalence ~1% Higher incidence:

Learning Objectives. Controversies in Osteoporosis Prevention and Management. Etiology. Presenter Disclosure Information. Epidemiology.

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Tables of Normal Values (As of February 2005)

ENDOCRINE DISORDERS IN THALASSEMIA MAJOR: QUALITY OF LIFE BEYOND SURVIVAL

BMD: A Continuum of Risk WHO Bone Density Criteria

Guideline for the investigation and management of osteoporosis. for hospitals and General Practice

MAN SHORTER CAN MAKE A HOW OSTEOPOROSIS. Ask your doctor if you have osteoporosis and if Prolia may be right for you. AND WHAT YOU CAN DO NEXT

Women s Health in SMA. Silvana E. Ribaudo, MD Assistant Clinical Professor in Obstetrics & Gynecology Columbia University Medical Center

Osteoporosis Management

Fracture=Bone Attack:

Assessment and Treatment of Osteoporosis Professor T.Masud

Product: Denosumab (AMG 162) Clinical Study Report: month Primary Analysis Date: 21 November 2016 Page 1

Index. Rheum Dis Clin N Am 32 (2006) Note: Page numbers of article titles are in boldface type.

OSTEOPOROSIS AND WHAT TO DO AFTER A VERTEBRAL FRACTURE. Lydia Au Geriatrics Ng Teng Fong Hospital

Men and Osteoporosis So you think that it can t happen to you

10/26/2017. Aging Population = more osteoporosis

Page 1. New Developments in Osteoporosis. What s New in Osteoporosis

New therapies for osteoporosis. Dr.Shobhana Mohandas.MD.DGO.FICOG. Sun Medical centre, Thrissur, Kerala.

Shon E. Meek, M.D., Ph.D. Assistant Professor of Medicine

Recent advances in the management of osteoporosis

Osteoporosis Update. Case 2. Case 1: Monday morning, 8:15

Learning Objectives. Osteoporosis: Lest We Forget Secondary Causes. Question 1: (USPSTF) Screening (DEXA) A few words about DEXA scans

Genetic examination of diseases affecting bone development. and structure in newborns

Approach to a patient with hypercalcemia

OSTEOPOROSIS IN MEN. Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO

CATEGORY Endocrine System Review. Provide labels for the following diagram CHAPTER 13 BLM

Calcium Nephrolithiasis and Bone Health. Noah S. Schenkman, MD

Bone Health for Women: Current Research, Initiatives and Recommendations

Page 1. Updates in Osteoporosis. I have no conflicts of interest. What is osteoporosis? What s New in Osteoporosis

Skeletal Manifestations

ACP Colorado-Evidence Based Management of Osteoporosis

Transcription:

Diagnosis and Treatment of Osteoporosis Department of Endocrinology and Metabolism Ajou University School of Medicine Yoon-Sok CHUNG WCIM, COEX, Seoul, 27Oct2014

Case 1 71-year old woman Back pain Emergency Room Plain X-ray L2 T12 L1

What is the most effective method to detect recent fracture in spine? 1) Bone Mineral Density (BMD, DXA spine) 2) Ultrasonography (US, spine) 3) Computed Tomography (CT, spine) 4) Magnetic Resonance Imaging (MRI, spine) 5) Positron Emission Tomography (PET, FDG spine)

T12, L1, L2 Fractures T12 L1 L2 Plain X-ray MRI T2WI

What is the most effective method to detect recent fracture in spine? 1) Bone Mineral Density (BMD, DXA spine) 2) Ultrasonography (US, spine) 3) Computed Tomography (CT, spine) 4) Magnetic Resonance Imaging (MRI, spine) 5) Positron Emission Tomography (PET, FDG spine)

Diagnosis of Osteoporosis and Fracture Simple Method : Plain X-ray (Osteopenia and Fracture) Quantitative Method : Bone Mineral Density (Osteoporosis) Supportive Methods : Bone scan, MRI, CT (Fracture) Biochemical Methods : Bone turnover markers (Osteoporosis) Metabolic Bone Diseases and Rare Bone Diseases : Bone Biopsy (Differential Diagnosis and Confirm)

Case 2 52-year old Woman Low Bone Mineral Density Out-patient Clinic Fracture history (-) Menopause : 1 year ago Height 158cm Weight 45kg Blood Pressure 115/75mmHg Pulse Rate 76/min

Bone Mineral Density (BMD) Spine L1-4 T-score -1.8, Z-score -1.6 Femur total T-score -1.3, Z-score -1.2 T-L spine X-ray : Fracture (-) Routine Lab. : normal range

What is the most appropriate medication? 1) Calcium and Vitamin D (Ca + D) 2) Estrogen and Progesterone (HRT) 3) Selective Estrogen Receptor Modulator (SERM) 4) Bisphosphonate (BP) 5) Parathyroid hormone (PTH)

Medical Treatments (in Korea) Anti-resorptives 1. Bisphosphonates 2. SERM 3. Estrogen 4. Vitamin D 5. Calcitonin 6. Ipriflavone 7. Calcium 8. Denosumab (RANKL antibody) 9. Cathepsin K inhibitors Formation Stimulants 1. Androgen 2. Fluoride 3. Vitamin K 4. Parathyroid hormone 5. Strontium 6. Anti-sclerostin antibody

What is the most appropriate medication? 1) Calcium and Vitamin D (Ca + D) 2) Estrogen and Progesterone (HRT) 3) Selective Estrogen Receptor Modulator (SERM) 4) Bisphosphonate (BP) 5) Parathyroid hormone (PTH)

Case 3 74-year old woman Sustained wound after teeth extraction for 10 weeks Out-patient Clinic Type 2 DM Postmenopausal Osteoporosis

Patient had been taking 6 years of Osteoporosis Medication. What is the most possible drug for this condition? 1) Estrogen and Progesterone (HRT) 2) Selective Estrogen Receptor Modulator (SERM) 3) Calcitonin (CT) 4) Parathyroid hormone (PTH) 5) Bisphosphonate (BP)

Adverse Effects of Bisphosphonates Gastrointestinal disturbance (Erosion, Ulcer) Acute Phase Reaction (Flu-like illness) Hypocalcemia Ocular complication (Conjunctivitis, Uveitis) Osteonecrosis of the Jaw (ONJ) Atypical Femur Fracture

Patient had been taking 6 years of Osteoporosis Medication. What is the most possible drug for this condition? 1) Estrogen and Progesterone (HRT) 2) Selective Estrogen Receptor Modulator (SERM) 3) Calcitonin (CT) 4) Parathyroid hormone (PTH) 5) Bisphosphonate (BP)

Case 4 43-year old woman Low Bone Mineral Density Out-patient Clinic Fracture history (-) LNMP : 1 month ago Height 162cm Weight 45kg Blood Pressure 115/75mmHg Pulse Rate 68/min

Bone Mineral Density (BMD) Spine L1-4 T-score -2.7, Z-score -1.3 Femur total T-score -2.2, Z-score -1.1 T-L spine X-ray : no fracture Routine Lab. : normal range

What is the most appropriate medication? 1) Calcium and Vitamin D (Ca + D) 2) Estrogen and Progesterone (HRT) 3) Selective Estrogen Receptor Modulator (SERM) 4) Parathyroid hormone (PTH) 5) Bisphosphonate (BP)

Premenopausal Osteoporosis Calcium and Vitamin D : usual risk (not high risk) Estrogen : premature ovarian failure SERM : not a candidate PTH : short-term (no evidence) Bisphosphonate : not a good candidate (fetal risk)

Bone Mineral Density (BMD) Spine L1-4 T-score -2.7, Z-score -1.3 Femur total T-score -2.2, Z-score -1.1 T-L spine X-ray : no fracture Routine Lab. : normal range

Case 4 43-year old woman Low Bone Mineral Density Out-patient Clinic Fracture history (-) LNMP : 1 month ago Height 162cm Weight 45kg Blood Pressure 115/75mmHg Pulse Rate 68/min

Bone Mineral Density (BMD) Spine L1-4 T-score -2.7, Z-score -1.3 Femur total T-score -2.2, Z-score -1.1 T-L spine X-ray : no fracture Routine Lab. : normal range

What is the most appropriate medication? 1) Calcium and Vitamin D (Ca + D) 2) Estrogen and Progesterone (HRT) 3) Selective Estrogen Receptor Modulator (SERM) 4) Parathyroid hormone (PTH) 5) Bisphosphonate (BP)

Premenopausal Osteoporosis Calcium and Vitamin D : usual risk (not high risk) Estrogen : premature ovarian failure SERM : not a candidate PTH : short-term (no evidence) Bisphosphonate : not a good candidate (fetal risk)

Case 5 55-year old man Low Bone Mineral Density Out-patient Clinic Fracture history (-) Medication history (-) Height 173cm Weight 65kg Blood Pressure 125/85mmHg Pulse Rate 78/min

Bone Mineral Density (BMD) Spine L1-4 T-score -2.8, Z-score -2.3 Femur total T-score -2.4, Z-score -2.1 T-L spine X-ray : Genant Grade 1 (mild degree) T12 compression fracture

What is the most common laboratory abnormality expected in this patient as Korean? 1) Serum Testosterone 2) Serum Cortisol, ACTH 3) Serum TSH and Free T4 4) Serum Prolactin and GH 5) Serum 25OHD and PTH

Laboratory Evaluation for Male Osteoporosis as Secondary Causes Additional laboratory tests if indicated Initial laboratory tests Complete chemistry profile (including alkaline phosphatase) Complete blood count Calcium, phosphorus 25 hydroxyvitamin D Testosterone Urinary calcium excretion 24 hour urine for free cortisol FSH, LH Prolactin Magnesium 1,25 dihydroxyvitamin D Intact PTH TSH Celiac screen Serum protein electrophoresis/urine protein electrophoresis Erythrocyte sedimentation rate Rheumatoid factor Ferritin and carotene levels Iron and total iron binding capacity Serum tryptase and histamine levels Homocysteine Skin biopsy for connective tissue disorders COL1A genetic testing for osteogenesis imperfecta Serum and urine markers of bone turnover Late-Onset Hypogonadism. Korean Society for Aging Male Research. Korean Andrological Society 남성골다공증. 정윤석. In 남성갱년기. 대한남성갱년기학회및대한남성과학회. 군자출판사. Pp 165-181, 2009

Case 5 55-year old man Low Bone Mineral Density Out-patient Clinic Fracture history (-) Medication history (-) Height 173cm Weight 65kg Blood Pressure 125/85mmHg Pulse Rate 78/min

What is the most common laboratory abnormality expected in this patient as Korean? 1) Serum Testosterone 2) Serum Cortisol, ACTH 3) Serum TSH and Free T4 4) Serum Prolactin and GH 5) Serum 25OHD and PTH

What is the most common laboratory abnormality expected in this patient as Korean? 1) Serum Testosterone, LH 2) Serum Cortisol, ACTH 3) Serum TSH and Free T4 4) Serum Prolactin and GH 5) Serum 25OHD and PTH